These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Mitochondrial ferritin protects SH-SY5Y cells against H Guan H; Yang H; Yang M; Yanagisawa D; Bellier JP; Mori M; Takahata S; Nonaka T; Zhao S; Tooyama I Exp Neurol; 2017 May; 291():51-61. PubMed ID: 28163159 [TBL] [Abstract][Full Text] [Related]
4. Dopamine induces autophagic cell death and alpha-synuclein increase in human neuroblastoma SH-SY5Y cells. Gómez-Santos C; Ferrer I; Santidrián AF; Barrachina M; Gil J; Ambrosio S J Neurosci Res; 2003 Aug; 73(3):341-50. PubMed ID: 12868068 [TBL] [Abstract][Full Text] [Related]
5. Effect of the overexpression of wild-type or mutant alpha-synuclein on cell susceptibility to insult. Lee M; Hyun D; Halliwell B; Jenner P J Neurochem; 2001 Feb; 76(4):998-1009. PubMed ID: 11181819 [TBL] [Abstract][Full Text] [Related]
7. Oxidative stress partially contributes to iron-induced α-synuclein aggregation in SK-N-SH cells. Li W; Jiang H; Song N; Xie J Neurotox Res; 2011 Apr; 19(3):435-42. PubMed ID: 20383623 [TBL] [Abstract][Full Text] [Related]
8. Alpha-synuclein aggregation is involved in the toxicity induced by ferric iron to SK-N-SH neuroblastoma cells. He Q; Song N; Xu H; Wang R; Xie J; Jiang H J Neural Transm (Vienna); 2011 Mar; 118(3):397-406. PubMed ID: 20690031 [TBL] [Abstract][Full Text] [Related]
9. Desferrioxamine-caffeine (DFCAF) as a cell permeant moderator of the oxidative stress caused by iron overload. Alta EC; Goswami D; Machini MT; Silvestre DM; Nomura CS; Espósito BP Biometals; 2014 Dec; 27(6):1351-60. PubMed ID: 25265871 [TBL] [Abstract][Full Text] [Related]
10. Triphenylphosphonium-desferrioxamine as a candidate mitochondrial iron chelator. Alta RYP; Vitorino HA; Goswami D; Terêsa Machini M; Espósito BP Biometals; 2017 Oct; 30(5):709-718. PubMed ID: 28770399 [TBL] [Abstract][Full Text] [Related]
11. Chronic intranasal deferoxamine ameliorates motor defects and pathology in the α-synuclein rAAV Parkinson's model. Febbraro F; Andersen KJ; Sanchez-Guajardo V; Tentillier N; Romero-Ramos M Exp Neurol; 2013 Sep; 247():45-58. PubMed ID: 23531432 [TBL] [Abstract][Full Text] [Related]
12. Differential cytotoxicity of human wild type and mutant alpha-synuclein in human neuroblastoma SH-SY5Y cells in the presence of dopamine. Moussa CE; Wersinger C; Tomita Y; Sidhu A Biochemistry; 2004 May; 43(18):5539-50. PubMed ID: 15122920 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of alpha-synuclein decreased viability and enhanced sensitivity to prostaglandin E(2), hydrogen peroxide, and a nitric oxide donor in differentiated neuroblastoma cells. Prasad JE; Kumar B; Andreatta C; Nahreini P; Hanson AJ; Yan XD; Prasad KN J Neurosci Res; 2004 May; 76(3):415-22. PubMed ID: 15079871 [TBL] [Abstract][Full Text] [Related]
14. Deferoxamine-induced neurite outgrowth and synapse formation in postnatal rat dorsal root ganglion (DRG) cell cultures. Nowicki M; Kosacka J; Spanel-Borowski K; Borlak J Eur J Cell Biol; 2009 Oct; 88(10):551-62. PubMed ID: 19581022 [TBL] [Abstract][Full Text] [Related]
15. Role of cytochrome c as a stimulator of alpha-synuclein aggregation in Lewy body disease. Hashimoto M; Takeda A; Hsu LJ; Takenouchi T; Masliah E J Biol Chem; 1999 Oct; 274(41):28849-52. PubMed ID: 10506125 [TBL] [Abstract][Full Text] [Related]
16. Dopamine transporter-mediated cytotoxicity of 6-hydroxydopamine in vitro depends on expression of mutant alpha-synucleins related to Parkinson's disease. Lehmensiek V; Tan EM; Liebau S; Lenk T; Zettlmeisl H; Schwarz J; Storch A Neurochem Int; 2006 Apr; 48(5):329-40. PubMed ID: 16406146 [TBL] [Abstract][Full Text] [Related]
17. Iron is not involved in oxidative stress-mediated cytotoxicity of doxorubicin and bleomycin. Kaiserová H; den Hartog GJ; Simůnek T; Schröterová L; Kvasnicková E; Bast A Br J Pharmacol; 2006 Dec; 149(7):920-30. PubMed ID: 17031387 [TBL] [Abstract][Full Text] [Related]
18. 1-Benzyl-1,2,3,4-tetrahydroisoquinoline, a Parkinsonism-inducing endogenous toxin, increases alpha-synuclein expression and causes nuclear damage in human dopaminergic cells. Shavali S; Carlson EC; Swinscoe JC; Ebadi M J Neurosci Res; 2004 May; 76(4):563-71. PubMed ID: 15114628 [TBL] [Abstract][Full Text] [Related]
19. Dose- and time-dependent alpha-synuclein aggregation induced by ferric iron in SK-N-SH cells. Li WJ; Jiang H; Song N; Xie JX Neurosci Bull; 2010 Jun; 26(3):205-10. PubMed ID: 20502498 [TBL] [Abstract][Full Text] [Related]
20. Benefits of Iron Chelators in the Treatment of Parkinson's Disease. Zeng X; An H; Yu F; Wang K; Zheng L; Zhou W; Bao Y; Yang J; Shen N; Huang D Neurochem Res; 2021 May; 46(5):1239-1251. PubMed ID: 33646533 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]